Orgenesis (ORGS) shares fell almost 42% in Friday's premarket activity after it disclosed in a regulatory filing that it has been notified that the Nasdaq hearings panel has decided to delist the company's shares and suspend trading, effective Monday.
Nasdaq opted to delist the company for failing to meet the exchange's bid price and equity requirements, the filing said.
The delisting will be complete after the appeal periods have lapsed, the company said. In the interim, the company said it intends to begin trading under the symbol, "ORGS," on the OTC Markets effective Monday.
Price: 1.88, Change: -1.36, Percent Change: -41.94
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments